Blood test for lung cancer screening in smokers and former smokers
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 50 years old (or 55–74 if joining from the ZORALCS study)
- Have smoked cigarettes or be willing to participate without smoking history (depending on study group)
- Provide a blood sample for biomarker testing
- Be available to complete study visits as scheduled
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
This study is testing a new blood test that looks for DNA from lung cancer cells in your blood. It aims to see if the test can find lung cancer early, even before symptoms start.
This study is testing a new blood test to help diagnose lung cancer by looking at certain markers in your DNA. Researchers want to see if this test can accurately find lung cancer, which could lead to earlier detection.
This trial uses a simple blood test (liquid biopsy) to find tumor DNA in people suspected of having lung cancer. The goal is to learn if this test can help doctors make better treatment decisions without needing a tissue sample.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
Hear when a new Epigenetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.